Michael E. Plazak

ORCID: 0000-0001-8616-4724
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mechanical Circulatory Support Devices
  • Cardiac Structural Anomalies and Repair
  • Heart Failure Treatment and Management
  • Transplantation: Methods and Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Polyomavirus and related diseases
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Parvovirus B19 Infection Studies
  • Cardiac Arrest and Resuscitation
  • Venous Thromboembolism Diagnosis and Management
  • COVID-19 Clinical Research Studies
  • Antenna Design and Analysis
  • Lipoproteins and Cardiovascular Health
  • Clinical Nutrition and Gastroenterology
  • Long-Term Effects of COVID-19
  • Acute Ischemic Stroke Management
  • Poisoning and overdose treatments
  • Urticaria and Related Conditions
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Mitochondrial Function and Pathology
  • Case Reports on Hematomas
  • Inflammatory mediators and NSAID effects
  • Platelet Disorders and Treatments
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Issues in Pregnancy

University of Maryland, Baltimore
2018-2024

University of Maryland Medical Center
2018-2024

Thrombocytopenia is common during extracorporeal membrane oxygenation (ECMO), and platelets are sometimes transfused to meet arbitrary goals. We performed a retrospective cohort study of veno-arterial (VA) ECMO patients from single academic medical center explored the relationship between platelet transfusion in-hospital mortality using multivariable logistic regression. One hundred eighty-eight VA were included in study. Ninety-one (48.4%) ECMO. Patients who received had more coronary...

10.1097/mat.0000000000001643 article EN ASAIO Journal 2021-12-28

Sensitization remains a barrier to heart transplantation (HT). Perioperative desensitization strategies have been described; however, paucity of evidence exists demonstrate efficacy and safety in HT.This single-center, retrospective study consisted adults who received an HT. was initiated if virtual crossmatch or flow-cytometry positive. Therapy plasmapheresis, intravenous immunoglobulin, rabbit antithymocyte globulin. Historical controls standard immunosuppression induction. The primary...

10.1097/txd.0000000000001111 article EN cc-by-nc-nd Transplantation Direct 2021-01-26

Advanced liver disease or cirrhosis is associated with an increased risk of infections; however, the impact high pretransplant model for end-stage (MELD) score on cytomegalovirus (CMV) viremia after transplantation unknown.This single-center, retrospective, cohort study evaluated CMV high-risk (CMV immunoglobulin G D+/R-) transplant recipients who received valganciclovir prophylaxis 3 months between 2009 and 2019. Patients were stratified by MELD <35 (low MELD) ≥35 (high MELD). The primary...

10.1111/tid.14001 article EN Transplant Infectious Disease 2022-12-12

Introduction Hypoalbuminemia is predictive of mortality in critically ill patients, especially those with cardiac etiologies illness. The objective this study was to determine the association albumin level pre-cannulation for veno-arterial (V-A) extracorporeal membrane oxygenation (ECMO) and important clinical hospital outcomes. Methods This a retrospective, observational cohort levels patients cardiogenic shock requiring V-A ECMO between December 2015 August 2021 single, high-volume center....

10.1177/02676591241288793 article EN Perfusion 2024-10-04

Introduction: Pregnancy in patients with advanced heart failure requiring left ventricular assist device (LVAD) support is risky and discouraged, though there are cases of successful deliveries. Hypothesis: A 29-year-old G3P2002 female history embolic cerebrovascular accident, postpartum hemorrhage, peripartum cardiomyopathy status-post HeartMate 3 (HM3) LVAD, became pregnant after intrauterine dislodgement. She elected to continue the pregnancy against advice maternal-fetal medicine (MFM)....

10.1161/circ.148.suppl_1.18267 article EN Circulation 2023-11-07

It remains unclear whether patients who will not accept allogeneic blood transfusion can be managed successfully with veno-arterial (V-A) extracorporeal membrane oxygenation (ECMO). The objective of our study was to determine what percentage V-A ECMO were without transfusion.This a retrospective, observational cohort cardiogenic shock requiring between January 2016 and 2019. primary outcome avoidance any transfusion.Of the 206 included, 23 (11.2%) transfusion. Fourteen (60.9%) avoided during...

10.1177/02676591221119015 article EN Perfusion 2022-08-11

Approximately 795 000 people in the United States experience stroke annually, with 610 initial and 185 recurrent events.1 The majority of these events (87%) are ischemic nature.1 Stroke ranks fifth among all causes death States, although rates mortality due to have decreased overall by 2.3% between 2005 2015.1 Given aging population it is likely that incidence will continue rise. The management patients acute (AIS) continues evolve, recent publication several trials evaluating...

10.1177/0018578718791504 article EN Hospital Pharmacy 2018-08-07

We previously reported low rates of pump thrombosis and hemorrhagic stroke, but increased bleeding, under our original antithrombosis protocol (P1) in HeartWare recipients. designed implemented a revised (P2) to reduce complexity bleeding. Thrombelastography PFA-100 guide antiplatelet titration. Goals for P2 were altered decrease use anticoagulation intensity. compared the incidence gastrointestinal bleeding (GIB), embolic (eCVA) (hCVA) (PT), total (GIB+hCVA), (eCVA+PT), events between P1...

10.1111/aor.14055 article EN Artificial Organs 2021-08-23

Background: Patients with severe COVID-19 related respiratory failure may require veno-venous extracorporeal membrane oxygenation (VV ECMO). After decannulation, patients on VV ECMO have historically had high percentages of cannula-associated deep vein thrombosis (CaDVT). Due to their hypercoagulable state and prolonged course ECMO, we hypothesized that would experience a higher rate CaDVT when compared non-COVID-19 counterparts. We also described the association between location size...

10.1097/01.mat.0000841056.25733.a8 article EN ASAIO Journal 2022-06-01
Coming Soon ...